Pharmacy

Your Article Summary

See Latest Articles

Drug Interactions with New and Investigational Antiretrovirals
Clinical Pharmacokinetics, 06/09/09

Brown KC et al. - This article summarizes the drug interaction potential of new and investigational protease inhibitors, non-nucleoside reverse transcriptase inhibitors, chemokine receptor antagonists, integrase inhibitors and maturation inhibitors.

Today in Drug Interactions...keeping you current

Receive free subspecialty "5-minute updates" via email

Subcutaneous Sumatriptan Pharmacokinetics: Delimiting the Monoamine Oxidase Inhibitor Effect
Headache: The Journal of Head and Face Pain, 12/08/09

Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin
American Journal of Health-System Pharmacy, 12/08/09

Potential interactions between cilostazol and probucol: A two-part, single-dose, open-label study in healthy Korean male volunteers
Clinical Therapeutics, 12/07/09

 See all of Drug Interactions

Today in Pharmacokinetics...keeping you current

Receive free subspecialty "5-minute updates" via email

Safety and pharmacokinetics of subcutaneous ceftriaxone administered with or without recombinant human hyaluronidase (rHuPH20) versus intravenous ceftriaxone administration in adult volunteers
Current Medical Research and Opinion, 12/08/09

Subcutaneous Sumatriptan Pharmacokinetics: Delimiting the Monoamine Oxidase Inhibitor Effect
Headache: The Journal of Head and Face Pain, 12/08/09

Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study
Annals of Oncology, 12/07/09

 See all of Pharmacokinetics